课题基金 / 基金详情

Treatment for acute/chronic ischemic neuronal injury using vanadate

Treatment for acute/chronic ischemic neuronal injury using vanadate
钒酸盐治疗急/慢性缺血性神经元损伤
批准号:
15591534
负责人:
MORIOKA Motohiro
金额:
$1.98万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

MORIOKA Motohiro的其他基金

相似基金

相关文献

中文摘要
翻译
原钒酸盐是蛋白酪氨酸磷酸酶的竞争性抑制剂。一些已报道的生物效应是其胰岛素模拟特性和激活磷酸肌肽3-激酶和细胞外信号调节激酶(ERK)。作者先前报道了其通过Akt和ERK激活沙鼠海马CA1神经元在短暂性前脑缺血后延迟神经元死亡的神经保护作用。本研究研究了脑缺血后腹腔注射原钒酸钠(50 mmol/l生理盐水中原钒酸钠2 l/kg)对大脑中动脉闭塞大鼠的神经保护作用。缺血后1天和28天分别评价神经元的缺血性损伤。在缺血后1天和28天,正钒酸盐对皮质的神经保护作用显著,而对尾状壳核(缺血核心)的神经保护作用不显著。原钒酸盐组再灌注后Akt、ERK活性维持;生理盐水组明显减少。血糖水平下降,但在正常范围内。仅在再灌注后0 h,局部脑血流量低于生理盐水组。这些数据表明,原钒酸盐对短暂性大脑中动脉闭塞大鼠具有神经保护作用,这种作用是通过激活Akt和ERK介导的。此外,低血糖水平和局部脑血流的逐渐恢复可能有助于神经保护。缺血后注射钒酸钠。SVZ组Budr/double cortin阳性细胞数量明显减少。由此可见,钒酸盐对缺血后的祖细胞有诱导作用。钒酸盐可能具有诱导神经元再生的潜力。需要进一步的调查和治疗试验。
英文摘要
Orthovanadate is a competitive inhibitor of protein tyrosine phosphatases. Some of its reported biologic effects are its insulin mimetic property and its activation of phosphoinositide 3-kinase and extracellular-signal regulated kinase(ERK). The authors previously reported its neuroprotective effect on delayed neuronal death of gerbil hippocampal CA1 neurons via Akt and ERK activation after transient forebrain ischemia. In the present study, the neuroprotective effect of postischemic intraperitoneal administration of sodium orthovanadate(2 l/kg of 50-mmol/l sodium orthovanadate in saline) was investigated in rats with transient middle cerebral artery occlusion. Ischemic neuronal injury was evaluated 1 day and 28 days after ischemia. The neuroprotective effect of orthovanadate was significant in the cortex but not the caudate putamen(ischemic core) at both 1 and 28 days after ischemia. In orthovanadate group, the activities of Akt and ERK were maintained after reperfusion ; they were decreased in saline group. Blood glucose level decreased but within normal range.Regional cerebral blood flow was lower than that of saline group only at 0 hours after reperfusion. These data suggest that orthovanadate has neuroprotective effects in rats with transient middle cerebral artery occlusion and that these effects are mediated by Akt and ERK activation. Furthermore, low blood glucose levels and gradual recovery of regional cerebral blood flow may contribute to neuroprotection.Next, we injected vanadte after ischemia. The number of Budr/double cortin positive cells decreased remarkably in SVZ. Thus we concluded that vanadate induced progenitor cells after ischemia.Vanadate may have a potential that induced neuronal regeneration. Further investigation and trial for treatment were needed.
期刊论文(44)
专著(0)
科研奖励(0)
会议论文
Tajiri S, Oyadomari S, Yano S, Morioka M et al.: "Ischemia-induced neuronal cell death is mediated by the endoplasmic reticulum stress pathway involving CHOP"Cell Death Differ.. 11(4). 403-415 (2004)
Tajiri S、Oyadomari S、Yano S、Morioka M 等人:“缺血诱导的神经元细胞死亡是由涉及 CHOP 的内质网应激途径介导的”细胞死亡差异.. 11(4)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: 10.3171/jns.2003.99.6.0960
发表时间: 2003-12-01
期刊: JOURNAL OF NEUROSURGERY
影响因子: 4.1
作者: [Hamada, J, Kai, Y, Ushio, Y]
通讯作者: Ushio, Y
DOI: 10.1038/sj.cdd.4401365
发表时间: 2004-04-01
期刊: CELL DEATH AND DIFFERENTIATION
影响因子: 12.4
作者: [Tajiri, S, Oyadomari, S, Mori, M]
通讯作者: Mori, M
T Hara, J Hamada, S Yano, M Morioka, et al.: "CREB is required for acquisition of ischemic tolerance in gerbil hippocampal CA1 region"J.Neurochem.. 86. 805-814 (2003)
T Hara、J Hamada、S Yano、M Morioka 等人:“沙鼠海马 CA1 区域的缺血耐受性的获得需要 CREB”J.Neurochem.. 86. 805-814 (2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 14 条
    Paho-physiologocal study for moyamoya disease : proteomix and neuroimaging analysis
    • 批准号:
      23592096
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.24万
    • 财政年份:
      2011
    • 负责人:
      MORIOKA Motohiro
    • 依托单位:
    The study of common cell death pathway between Altzheimer disease and ischemic neuronal cell death
    • 批准号:
      17591519
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.98万
    • 财政年份:
      2005
    • 负责人:
      MORIOKA Motohiro
    • 依托单位:
    The role of phosphorylation reaction of tau factor in ischemic neuronal cell death
    • 批准号:
      13671445
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2001
    • 负责人:
      MORIOKA Motohiro
    • 依托单位:
    海外基金